The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target

[1]  G. Hu,et al.  miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression , 2022, Proceedings of the National Academy of Sciences.

[2]  Zhengrong Li,et al.  Circular RNA hsa_circ_0001658 regulates apoptosis and autophagy in gastric cancer through microRNA-182/Ras-related protein Rab-10 signaling axis , 2022, Bioengineered.

[3]  B. Baradaran,et al.  Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression. , 2021, Life sciences.

[4]  B. Baradaran,et al.  Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer. , 2020, Gene.

[5]  K. Varley,et al.  The lingering mysteries of metastatic recurrence in breast cancer , 2020, British journal of cancer.

[6]  Wujun Xiong,et al.  MicroRNA-182 Promotes Cell Migration by Targeting Programmed Cell Death 4 in Hepatocellular Carcinoma Cells , 2020, OncoTargets and therapy.

[7]  G. Nie,et al.  Circular RNA 000554 represses epithelial‐mesenchymal transition in breast cancer by regulating microRNA‐182/ZFP36 axis , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Xinhao Chen,et al.  MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C. , 2020, Cancer letters.

[9]  Min Zhou,et al.  Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis. , 2020, Pathology, research and practice.

[10]  Hua Li,et al.  MicroRNA-182 Suppresses Malignant Melanoma Proliferation by Targeting RECK. , 2020, Clinical Laboratory.

[11]  Jiachun Lu,et al.  Long non-coding RNA AGER-1 inhibits colorectal cancer progression through sponging miR-182 , 2020, The International journal of biological markers.

[12]  B. Baradaran,et al.  MicroRNA‐193a and taxol combination: A new strategy for treatment of colorectal cancer , 2020, Journal of cellular biochemistry.

[13]  Shiming Liu,et al.  MiR-182 promotes glioma progression by targeting FBXW7 , 2020, Journal of the Neurological Sciences.

[14]  Hao Hu,et al.  A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR‐182‐5p , 2020, Journal of cellular biochemistry.

[15]  B. Baradaran,et al.  microRNA-181 serves as a dual-role regulator in the development of human cancers. , 2019, Free radical biology & medicine.

[16]  Hulun Li,et al.  MicroRNA 182 promotes T helper 1 cell by repressing hypoxia induced factor 1 alpha in experimental autoimmune encephalomyelitis , 2019, European journal of immunology.

[17]  Muhammet Uslupehlivan,et al.  Computational analysis of the structure, glycosylation and CMP binding of human ST3GAL sialyltransferases. , 2019, Carbohydrate research.

[18]  Jindan Zheng,et al.  The long noncoding RNA PCGEM1 promotes cell proliferation, migration and invasion via targeting the miR-182/FBXW11 axis in cervical cancer , 2019, Cancer Cell International.

[19]  T. Buchler,et al.  5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. , 2019, Pharmacology & therapeutics.

[20]  Hu Li,et al.  The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer. , 2019, Cancer letters.

[21]  J. Hoheisel,et al.  GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond , 2019, Journal of cellular physiology.

[22]  Jinqiu Tao,et al.  Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression , 2019, International journal of biological sciences.

[23]  Hong Chang,et al.  LINC01018 confers a novel tumor-suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p. , 2019, American journal of physiology. Gastrointestinal and liver physiology.

[24]  Qian Yang,et al.  Diminished LINC00173 expression induced miR-182-5p accumulation promotes cell proliferation, migration and apoptosis inhibition via AGER/NF-κB pathway in non-small-cell lung cancer. , 2019, American journal of translational research.

[25]  G. Mann,et al.  RAB27A promotes melanoma cell invasion and metastasis via regulation of pro‐invasive exosomes , 2019, International journal of cancer.

[26]  Chenyu Zhu,et al.  miR-383 Inhibited the Cell Cycle Progression of Gastric Cancer Cells via Targeting Cyclin E2. , 2019, DNA and cell biology.

[27]  Xudong Zhang,et al.  miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP. , 2019, International Journal of Biochemistry and Cell Biology.

[28]  Qiwei Yang,et al.  Potential Regulatory Effects of miR-182-3p in Osteosarcoma via Targeting EBF2 , 2019, BioMed research international.

[29]  B. Xiong,et al.  MiR-182-5p inhibited proliferation and metastasis of colorectal cancer by targeting MTDH. , 2019, European review for medical and pharmacological sciences.

[30]  Gang Chen,et al.  MiR‐182 enhances radioresistance in non‐small cell lung cancer cells by regulating FOXO3 , 2019, Clinical and experimental pharmacology & physiology.

[31]  E. Papanikolaou,et al.  BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro , 2019, Human reproduction.

[32]  Yue Zhao,et al.  MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells , 2019, Yonsei medical journal.

[33]  F. Bray,et al.  Global trends in colorectal cancer mortality: projections to the year 2035 , 2019, International journal of cancer.

[34]  Dong Hoon Lee,et al.  Resveratrol epigenetically regulates the expression of zinc finger protein 36 in non‑small cell lung cancer cell lines. , 2018, Oncology reports.

[35]  A. Avan,et al.  Hereditary breast cancer; Genetic penetrance and current status with BRCA , 2018, Journal of cellular physiology.

[36]  Y. Li,et al.  MicroRNA-182-5p attenuates cerebral ischemia-reperfusion injury by targeting Toll-like receptor 4. , 2018, Biochemical and biophysical research communications.

[37]  Xiu-feng Cao,et al.  Circ-SFMBT2 promotes the proliferation of gastric cancer cells through sponging miR-182-5p to enhance CREB1 expression , 2018, Cancer management and research.

[38]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[39]  Jilong Ma,et al.  MicroRNA-182 promoted esophageal squamous cell carcinoma cell growth and metastasis via targeting YWHAG. , 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[40]  R. Dahiya,et al.  Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression , 2018, Molecular Cancer Research.

[41]  Jian Wang,et al.  lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR‑182‑5p/FOXO3a axis. , 2018, Oncology reports.

[42]  Hongyu Liu,et al.  miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene , 2018, Journal of experimental & clinical cancer research : CR.

[43]  Xiaosong Qin,et al.  miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells , 2018, Cancer Gene Therapy.

[44]  Shukui Wang,et al.  Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer , 2018, Cancer management and research.

[45]  Hao Chang,et al.  MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer. , 2018, American journal of translational research.

[46]  Hui Zhao,et al.  Identification of the tumor-suppressive function of circular RNA FOXO3 in non-small cell lung cancer through sponging miR-155 , 2018, Molecular medicine reports.

[47]  Y. Shao,et al.  MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[48]  Zhao-You Tang,et al.  miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a , 2018, Journal of Hematology & Oncology.

[49]  Y. Li,et al.  MiR‐182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene , 2018, Molecular carcinogenesis.

[50]  Ping Liu,et al.  RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182/HOXA9. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[51]  T. Catela Ivković,et al.  microRNAs as cancer therapeutics: A step closer to clinical application. , 2017, Cancer letters.

[52]  Dong-Mei Wu,et al.  MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9 , 2017, Oncotarget.

[53]  Erguang Li,et al.  High level of homeobox A9 and PBX homeobox 3 expression in gastric cancer correlates with poor prognosis , 2017, Oncology letters.

[54]  Jianchao Liu,et al.  MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer , 2017, Oncology letters.

[55]  Yanfeng Liu,et al.  Upregulation of microRNA‐135b and microRNA‐182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway , 2017, Molecular carcinogenesis.

[56]  J. Yu,et al.  CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630 , 2017, Aging.

[57]  J. Liang,et al.  miR-340 suppresses tumor growth and enhances chemosensitivity of colorectal cancer by targeting RLIP76. , 2017, European review for medical and pharmacological sciences.

[58]  Zongze He,et al.  The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP. , 2017, Archives of biochemistry and biophysics.

[59]  Liyan Bi,et al.  miR-182-5p improves the viability, mitosis, migration, and invasion ability of human gastric cancer cells by down-regulating RAB27A , 2017, Bioscience reports.

[60]  Laising Yen,et al.  Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis. , 2017, Cancer research.

[61]  A. Moridnia,et al.  Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer , 2017, Cancer Gene Therapy.

[62]  Yan Li,et al.  Long non-coding RNA growth arrest specific transcript 5 acts as a tumour suppressor in colorectal cancer by inhibiting interleukin-10 and vascular endothelial growth factor expression , 2017, Oncotarget.

[63]  Weidan Ji,et al.  Targeting MicroRNAs in Cancer Gene Therapy , 2017, Genes.

[64]  J. Yu,et al.  MicroRNA-182 targets FOXF2 to promote the development of triple-negative breast cancer. , 2016, Neoplasma.

[65]  J. Ji,et al.  MicroRNA-182 promotes pancreatic cancer cell proliferation and migration by targeting β-TrCP2. , 2016, Acta biochimica et biophysica Sinica.

[66]  David Victor,et al.  Hepatocellular carcinoma: a review , 2016, Journal of hepatocellular carcinoma.

[67]  W. Jiang,et al.  MicroRNA-182-5p Ameliorates Liver Ischemia-Reperfusion Injury by Suppressing Toll-Like Receptor 4. , 2016, Transplantation proceedings.

[68]  F. Slack,et al.  OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer. , 2016, Cancer research.

[69]  D. Lobo,et al.  Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway. , 2016, Cancer research.

[70]  R. Bataller,et al.  Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation , 2016, Gut.

[71]  Xing Li,et al.  High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer , 2016, Scientific Reports.

[72]  Jar-Yi Ho,et al.  OncomiR miR‐96 and miR‐182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma , 2016, Molecular carcinogenesis.

[73]  A. Seth,et al.  MiR-182 Is Associated with Growth, Migration and Invasion in Prostate Cancer via Suppression of FOXO1 , 2015, Journal of Cancer.

[74]  Xu Hou,et al.  Effect of miR-340 on gastric cancer cell proliferation and apoptosis. , 2015, International journal of clinical and experimental pathology.

[75]  Yuncheng Wu,et al.  microRNA-182 inhibits the proliferation and migration of glioma cells through the induction of neuritin expression. , 2015, Oncology letters.

[76]  H. Ying,et al.  Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer , 2015, Scientific Reports.

[77]  Haiyang Xie,et al.  Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma , 2015, Journal of experimental & clinical cancer research : CR.

[78]  Xiaojun Yang,et al.  High Rab27A expression indicates favorable prognosis in CRC , 2015, Diagnostic Pathology.

[79]  R. Gregory,et al.  MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.

[80]  G. Lv,et al.  The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression , 2015, PloS one.

[81]  Gaoxiang Huo,et al.  miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a. , 2015, International journal of clinical and experimental pathology.

[82]  Zhongqiu Wang,et al.  miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer. , 2015, Oncology reports.

[83]  Lin Tang,et al.  MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer. , 2015, Oncology reports.

[84]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[85]  Fan Yang,et al.  FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer , 2015, Breast Cancer Research.

[86]  Q. Meng,et al.  Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4 , 2014, Cancer Gene Therapy.

[87]  A. Scorilas,et al.  Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients , 2014, Clinical chemistry and laboratory medicine.

[88]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[89]  Xian-Jin Xie,et al.  DOC-2/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapy. , 2014, International journal of radiation oncology, biology, physics.

[90]  Fang-ling Ning,et al.  MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4 , 2014, Diagnostic Pathology.

[91]  D. Fan,et al.  Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. , 2014, Cancer letters.

[92]  Linfu Xie,et al.  Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway , 2014, Molecular Cancer.

[93]  J. Yu,et al.  microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis , 2014, Journal of Translational Medicine.

[94]  Kwong Wai Choy,et al.  Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. , 2014, Gene.

[95]  J. Qin,et al.  Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1. , 2014, Gene.

[96]  J. Hung,et al.  Sp1-mediated microRNA-182 expression regulates lung cancer progression , 2014, Oncotarget.

[97]  S. Xie,et al.  Higher expression of circulating miR-182 as a novel biomarker for breast cancer , 2013, Oncology letters.

[98]  R. Aebersold,et al.  Structural features of Argonaute–GW182 protein interactions , 2013, Proceedings of the National Academy of Sciences.

[99]  F. Sarkar,et al.  Difluorinated-Curcumin (CDF) Restores PTEN Expression in Colon Cancer Cells by Down-Regulating miR-21 , 2013, PloS one.

[100]  M. Hou,et al.  Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. , 2013, Biochimica et biophysica acta.

[101]  R. Dahiya,et al.  MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer , 2013, PloS one.

[102]  R. Jenkins,et al.  Genetics of adult glioma. , 2012, Cancer genetics.

[103]  Yan Zeng,et al.  Biogenesis of Mammalian MicroRNAs: A Global View , 2012, Genom. Proteom. Bioinform..

[104]  D. Hu,et al.  Role of MicroRNA-182 in Posterior Uveal Melanoma: Regulation of Tumor Development through MITF, BCL2 and Cyclin D2 , 2012, PloS one.

[105]  Junling Shen,et al.  MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma , 2012, BMC Cancer.

[106]  M. Hussain.  Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of action , 2012, Cell and Tissue Research.

[107]  Min Liu,et al.  MicroRNA‐182 targets cAMP‐responsive element‐binding protein 1 and suppresses cell growth in human gastric adenocarcinoma , 2012, The FEBS journal.

[108]  M. Fukuda,et al.  EPI64 Protein Functions as a Physiological GTPase-activating Protein for Rab27 Protein and Regulates Amylase Release in Rat Parotid Acinar Cells* , 2011, The Journal of Biological Chemistry.

[109]  M. Gorospe,et al.  miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. , 2011, Molecular cell.

[110]  P. Malfertheiner,et al.  World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. , 2010, Journal of gastrointestinal and liver diseases : JGLD.

[111]  Fei Li,et al.  Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. , 2010, Biochemical and biophysical research communications.

[112]  A. Sudhakar,et al.  History of Cancer, Ancient and Modern Treatment Methods. , 2009, Journal of cancer science & therapy.

[113]  B. White,et al.  Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.

[114]  H. Osada,et al.  RECK negatively regulates matrix metalloproteinase-9 transcription. , 2009, Cancer research.

[115]  D. Polsky,et al.  Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor , 2009, Proceedings of the National Academy of Sciences.

[116]  Zissimos Mourelatos,et al.  MicroRNAs: Biogenesis and Molecular Functions , 2008, Brain pathology.

[117]  E. Lam,et al.  The emerging roles of forkhead box (Fox) proteins in cancer , 2007, Nature Reviews Cancer.

[118]  M. Kiriakidou,et al.  An mRNA m7G Cap Binding-like Motif within Human Ago2 Represses Translation , 2007, Cell.

[119]  A. Giordano,et al.  How does the human RUNX3 gene induce apoptosis in gastric cancer? Latest data, reflections and reactions , 2006, Cancer biology & therapy.

[120]  M. Thomas,et al.  Opportunities for targeted therapies in hepatocellular carcinoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[121]  N. Rao,et al.  The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. , 2005, Cancer cell.

[122]  J. Wengel,et al.  Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology. , 2004, Oligonucleotides.

[123]  E. Rosen,et al.  BRCA1 gene in breast cancer , 2003, Journal of cellular physiology.

[124]  M. Berger,et al.  Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. , 2001, Cancer research.

[125]  Marc Montminy,et al.  Transcriptional regulation by the phosphorylation-dependent factor CREB , 2001, Nature Reviews Molecular Cell Biology.

[126]  S. Li,et al.  MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway. , 2018, European review for medical and pharmacological sciences.

[127]  Yousef Ahmed Fouad,et al.  Revisiting the hallmarks of cancer. , 2017, American journal of cancer research.

[128]  X. Wang,et al.  MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R. , 2016, Neoplasma.

[129]  B. Xiong,et al.  MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. , 2013, International journal of oncology.

[130]  Joerg E Braun,et al.  The role of GW182 proteins in miRNA-mediated gene silencing. , 2013, Advances in experimental medicine and biology.

[131]  E. Chan,et al.  Ten Years of Progress in GW/P Body Research , 2013, Advances in Experimental Medicine and Biology.

[132]  A. Riker,et al.  Up-Regulation of miR-182 Expression after Epigenetic Modulation of Human Melanoma Cells , 2013, Annals of Surgical Oncology.

[133]  J. R. Kelley,et al.  Gastric cancer epidemiology and risk factors. , 2003, Journal of clinical epidemiology.

[134]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[135]  R. Pollack,et al.  Cancer biology. , 1978, Science.